Clinical Trial Update: Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of triple therapy with valsartan, hydrochlorothiazide, and amlodipine in patients with hypertension; study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• DIOVAN (valsartan)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• NORVASC (amlodipine besylate)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED